Abstract
Using an agar dilution technique, we compared the activities of pristinamycin and its components PIA and PIIA with those of penicillin G, cefoxitin, chloramphenicol, metronidazole, and clindamycin against 200 strains of anaerobic bacteria isolated from suppurative lesions. The antimicrobial activity of pristinamycin was similar to that of chloramphenicol. On the basis of these results and because of its antistaphylococcal and antistreptococcal activities and its absence of toxicity, pristinamycin might be a valuable therapeutic agent for treating mixed aerobic-anaerobic cutaneous infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cocito C. Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev. 1979 Jun;43(2):145–192. doi: 10.1128/mr.43.2.145-192.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Communiqué du Comité de l'Antibiogramme de la Société Française de la Microbiologie. Pathol Biol (Paris) 1985 May;33(5):295–296. [PubMed] [Google Scholar]
- Sutter V. L., Barry A. L., Wilkins T. D., Zabransky R. J. Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 1979 Oct;16(4):495–502. doi: 10.1128/aac.16.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkins T. D., Chalgren S. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 1976 Dec;10(6):926–928. doi: 10.1128/aac.10.6.926. [DOI] [PMC free article] [PubMed] [Google Scholar]